333.46
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $333.46, with a volume of 787.88K.
It is up +0.11% in the last 24 hours and up +4.21% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$333.11
Open:
$333.19
24h Volume:
787.88K
Relative Volume:
0.47
Market Cap:
$89.43B
Revenue:
$254.47B
Net Income/Loss:
$5.03B
P/E Ratio:
18.46
EPS:
18.06
Net Cash Flow:
$6.01B
1W Performance:
-0.39%
1M Performance:
+4.21%
6M Performance:
+4.28%
1Y Performance:
-4.99%
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CI
Cigna Group
|
333.46 | 89.43B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
UNH
Unitedhealth Group Inc
|
380.64 | 364.02B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
ELV
Elevance Health Inc
|
404.58 | 92.63B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
CVS
Cvs Health Corp
|
66.97 | 85.34B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
HUM
Humana Inc
|
249.53 | 31.20B | 117.76B | 1.21B | 2.39B | 9.95 |
Cigna Group Stock (CI) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
Jun-26-24 | Initiated | Piper Sandler | Overweight |
May-30-24 | Initiated | Robert W. Baird | Outperform |
Mar-06-24 | Initiated | Barclays | Overweight |
Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Nov-23-22 | Resumed | Morgan Stanley | Overweight |
Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Jun-17-22 | Initiated | Loop Capital | Hold |
May-27-22 | Resumed | Bernstein | Mkt Perform |
May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Dec-14-21 | Initiated | Goldman | Neutral |
Nov-17-21 | Initiated | Seaport Research Partners | Buy |
Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
Sep-10-21 | Initiated | Cowen | Market Perform |
Aug-06-21 | Reiterated | BofA Securities | Buy |
Aug-06-21 | Reiterated | Citigroup | Buy |
Aug-06-21 | Reiterated | Deutsche Bank | Buy |
Aug-06-21 | Reiterated | Jefferies | Buy |
Aug-06-21 | Reiterated | Mizuho | Buy |
Aug-06-21 | Reiterated | Oppenheimer | Outperform |
Aug-06-21 | Reiterated | Truist | Buy |
May-19-21 | Initiated | Wells Fargo | Equal Weight |
Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
Oct-18-19 | Initiated | Mizuho | Buy |
Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
Apr-23-19 | Initiated | UBS | Buy |
Jan-14-19 | Initiated | Stephens | Overweight |
Dec-24-18 | Initiated | Edward Jones | Buy |
Mar-13-18 | Initiated | Bernstein | Mkt Perform |
Mar-08-18 | Initiated | Barclays | Overweight |
Jan-03-18 | Initiated | Goldman | Neutral |
Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
Jun-12-17 | Initiated | Credit Suisse | Outperform |
Jun-07-17 | Initiated | Morgan Stanley | Overweight |
May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Health insurance company denies operation to man battling lung cancer - KHOU
Man Fighting Cancer Now Battling Insurance Company After Life-Saving Transplant Denied - Men's Journal
Cigna lung transplant denial: Insurance company denies Deron Wells, Santa Monica, CA man with lung cancer, life-saving transplant - ABC7 Chicago
We Think Cigna Group's (NYSE:CI) Robust Earnings Are Conservative - simplywall.st
Cigna insurance denies Santa Monica man a life-saving lung transplant as he was preparing to fly cross-country for procedure - ABC7 Los Angeles
The Cigna Group (CI): Among the Cheap ESG Stocks to Buy According to Hedge Funds - Yahoo Finance
11 Cheap ESG Stocks to Buy According to Hedge Funds - Insider Monkey
Cigna stock price target raised to $373 by Bernstein - Investing.com India
RBC Capital Adjusts Cigna Group Price Target to $371 From $355 - marketscreener.com
Cigna Group (CI) Stock Target Price Raised by Guggenheim | CI Stock News - GuruFocus
CFRA: Cigna Group ’faces industry-wide cost pressures’ By Investing.com - Investing.com South Africa
CFRA: Cigna Group ’faces industry-wide cost pressures’ - Investing.com Australia
Guggenheim Adjusts Cigna Group Price Target to $388 From $384, Maintains Buy Rating - marketscreener.com
Cigna (CI) Price Target Increased on Positive Outlook | CI Stock News - GuruFocus
Deutsche Bank Adjusts Cigna Group Price Target to $372 From $356, Maintains Buy Rating - marketscreener.com
Raymond James Raises Price Target on Cigna Group to $385 From $360 - marketscreener.com
Piper Sandler Raises Price Target for Cigna Group (CI) to $374 | CI Stock News - GuruFocus
Cigna Packs Healthy Punch As Q1 Beat Sends Shares Higher, Analysts Raise Targets - Benzinga
Leerink Partners Adjusts Price Target on Cigna Group to $365 From $325, Maintains Market Perform Rating - marketscreener.com
Cigna Group (CI) Maintains "Buy" Rating from Guggenheim | CI Stock News - GuruFocus
CI: Cigna Group Stock Receives Boost from Morgan Stanley Rating | CI Stock News - GuruFocus
Cigna Group (CI) Price Target Raised by Barclays Analyst | CI St - GuruFocus
TD Cowen Adjusts Cigna Group Price Target to $386 From $380, Maintains Buy Rating - marketscreener.com
Jefferies & Co Adjusts Cigna Group Price Target to $397 From $376, Maintains Buy Rating - marketscreener.com
Cigna (CI) Target Price Increased by TD Cowen | CI Stock News - GuruFocus
Piper Sandler Elevates Cigna (CI) Price Target Amid Strong Performance | CI Stock News - GuruFocus
Cigna (CI) Price Target Raised by Morgan Stanley Analyst | CI Stock News - GuruFocus
Cigna (CI) Sees Price Target Increase Following Promising Q1 Results | CI Stock News - GuruFocus
Jefferies lifts Cigna stock price target to $397, maintains buy rating - Investing.com
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock Ne - GuruFocus
Cigna (CI) Target Price Raised by Barclays Analyst | CI Stock News - GuruFocus
Cigna raises 2025 outlook after lower-than-expected cost trends - MSN
MHE Week in Review –Cigna Revenue Increase, Aetna’s Exit and More - Managed Healthcare Executive
The Return Trends At Cigna Group (NYSE:CI) Look Promising - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Raised EPS Guidance - Yahoo Finance
The Cigna Group (CI) Q1 2025 Earnings Call Highlights: Strong Re - GuruFocus
Cigna Reports Strong Q1 2025 Results and Raises Outlook - TipRanks
Decoding The Cigna Group (CI): A Strategic SWOT Insight - GuruFocus
Cigna: Q1 Earnings Snapshot - MySA
Cigna’s Earnings Call: Strong Growth and Strategic Innovations - TipRanks
Cigna reports strong Q1, completes Medicare divestiture - InsuranceNewsNet
JPMorgan Adjusts Cigna Group's Price Target to $405 From $438 - marketscreener.com
Cigna (CI) Launches ENGUIDE Pharmacy Amid Growing GLP-1 Demand - GuruFocus
Updated: Cigna’s First Quarter Revenue Increased 14% to $65.5 Billion - Managed Healthcare Executive
Cigna reports $1.3 billion quarterly profit and lifts 2025 forecast - Insurance Business America
Cigna benefits from low medical costs, posts $1.3B in revenue - Healthcare Finance News
Cigna (CI) Raises Full-Year Earnings Forecast After Strong Q1 Pe - GuruFocus
Cigna Q1 Earnings Beat Estimates on Evernorth Health Strength - TradingView
Cigna's Evernorth unveils 2 new programs aimed at GLP-1s - Fierce Healthcare
Cigna Earnings: Slight Increase in 2025 Outlook Despite Elevated Medical Utilization - Morningstar
Cigna (CI) Boosts 2025 EPS Guidance and Reports Robust Q1 Results - GuruFocus
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):